Delivery Order SPE2DR25D3501-SPE2DR26FL9BW
Award Date 11/20/25
Potential Completion Date 11/21/25
Potential Value $6.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $2,583.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/ml ampul 2.5ml, a pharmaceutical product used in the treatment of cystic fibrosis. The contract, awarded on October 24, 2025, with an ultimate completion date of October 27, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order was competitively awarded without...
- The Defense Logistics Agency awarded a delivery order valued at $8,168.13 to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/ml ampul 2.5ml, a pharmaceutical product used in the treatment of cystic fibrosis. This firm fixed price, non-set-aside delivery order was awarded on November 12, 2025, with an ultimate completion date of November 13, 2025. The award was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a $36,747.91 delivery order to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/ml ampuls (2.5 ml units) with an ultimate completion date of October 24, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for Pulmozyme 1 mg/mL ampules (2.5 mL) with a ceiling value of $7,189.14. This firm fixed-price delivery order, which will be completed by November 6, 2025, represents a pediatric and adult cystic fibrosis treatment sourced from AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract was awarded competitively with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/mL ampules (2.5 mL) valued at $9,517.19 under a firm fixed price contract. The award, issued on November 20, 2025, with an ultimate completion date of November 21, 2025, represents a single delivery order for this specialty pharmaceutical product used in the treatment of cystic fibrosis. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was selected through open...
- The Defense Logistics Agency awarded a delivery order valued at $10,890.84 to AmerisourceBergen Drug Corp for the supply of Pulmozyme 1 mg/mL ampul 2.5mL, a pharmaceutical product used in the treatment of cystic fibrosis. This firm fixed price delivery order, awarded on November 13, 2025, with completion targeted for November 14, 2025, represents a routine medical supply transaction executed under a competitive, non-set-aside procurement process. The product will be delivered to the contractor's...
- The Defense Logistics Agency awarded a $2,599.62 delivery order to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/ml ampules (2.5 ml) on September 9, 2025, with completion expected by September 10, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a single delivery order against AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Pulmozyme 1 mg/ml ampul 2.5ml, a pharmaceutical product used in the treatment of cystic fibrosis. This firm fixed price contract, valued at $5,167.20, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract was...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $20,533.25 to AmerisourceBergen Drug Corp for the supply of Pulmozyme 1 mg/ml ampul 2.5ml, a pharmaceutical product used in the treatment of cystic fibrosis. The contract was competitively awarded on August 12, 2025, under a firm fixed-price arrangement with an ultimate completion date of August 13, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Pulmozyme 1 mg/ml ampul 2.5ml, a pharmaceutical product commonly used in cystic fibrosis treatment. This non-set-aside, firm fixed-price delivery order has a ceiling value of $16,287.62 and an ultimate completion date of August 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...